Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000914208-26-000430·Invesco Ltd.
Schedule 13G ownership disclosure
Ligand Pharmaceuticals Inc
Common Stock · CUSIP: 53220K504
Event date: 2026-09-30
- Filing-level shares
- 1,520,911.00
- Percent of class
- 7.6%
- Invesco Ltd.
Shares: 1,520,911.00 · Class: 7.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000914208-26-000430
- Form type
- SCHEDULE 13G/A
- Filer
- Invesco Ltd.
- CIK
- CIK 914208
- Filed
- Nov 10, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership